Loss of ovarian function in mice results in abrogated skeletal muscle PPARdelta and FoxO1-mediated gene expression
- PMID: 19850007
- PMCID: PMC2829241
- DOI: 10.1016/j.bbrc.2009.10.072
Loss of ovarian function in mice results in abrogated skeletal muscle PPARdelta and FoxO1-mediated gene expression
Abstract
Menopause, the age-related loss of ovarian hormone production, promotes increased adiposity and associated metabolic pathology, but molecular mechanisms remain unclear. We previously reported that estrogen increases skeletal muscle PPARdelta expression in vivo, and transgenic mice overexpressing muscle-specific PPARdelta are reportedly protected from diet-induced obesity. We thus hypothesized that obesity observed in ovariectomized mice, a model of menopause, may result in part from abrogated expression of muscle PPARdelta and/or downstream mediators such as FoxO1. To test this hypothesis, we ovariectomized (OVX) or sham-ovariectomized (SHM) 10-week old female C57Bl/6J mice, and subsequently harvested quadriceps muscles 12weeks later for gene expression studies. Compared to SHM, muscle from OVX mice displayed significantly decreased expression of PPARdelta (3.4-fold), FoxO1 (4.5-fold), PDK-4 (2.3-fold), and UCP-2 (1.8-fold). Consistent with studies indicating PPARdelta and FoxO1 regulate muscle fiber type, we observed dramatic OVX-specific decreases in slow isoforms of the contractile proteins myosin light chain (11.1-fold) and troponin C (11.8-fold). In addition, muscles from OVX mice expressed 57% less myogenin (drives type I fiber formation), 2-fold more MyoD (drives type II fiber formation), and 1.6-fold less musclin (produced exclusively by type II fibers) than SHM, collectively suggesting a shift towards less type I oxidative fibers. Finally, and consistent with changes in PPARdelta and FoxO1 activity, we observed decreased expression of atrogin-1 (2.3-fold) and MuRF-1 (1.9-fold) in OVX mice. In conclusion, muscles from ovariectomized mice display decreased PPARdelta and FoxO1 expression, abrogated expression of downstream targets involved in lipid and protein metabolism, and gene expression profiles indicating less type I oxidative fibers.
Copyright (c) 2009 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Growth hormone increases mRNA levels of PPARdelta and Foxo1 in skeletal muscle of growth hormone deficient lit/lit mice.Endocr J. 2009;56(1):141-7. doi: 10.1507/endocrj.k08e-219. Epub 2008 Nov 8. Endocr J. 2009. PMID: 18997443
-
CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.J Biol Chem. 2008 May 23;283(21):14317-26. doi: 10.1074/jbc.M706478200. Epub 2008 Feb 28. J Biol Chem. 2008. PMID: 18308721 Free PMC article.
-
Inhibitory Regulation of FOXO1 in PPARδ Expression Drives Mitochondrial Dysfunction and Insulin Resistance.Diabetes. 2024 Jul 1;73(7):1084-1098. doi: 10.2337/db23-0432. Diabetes. 2024. PMID: 38656552
-
FoxO1 regulates muscle fiber-type specification and inhibits calcineurin signaling during C2C12 myoblast differentiation.Mol Cell Biochem. 2011 Feb;348(1-2):77-87. doi: 10.1007/s11010-010-0640-1. Epub 2010 Nov 16. Mol Cell Biochem. 2011. PMID: 21080037
-
FoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specification.Oncotarget. 2017 Feb 7;8(6):10662-10674. doi: 10.18632/oncotarget.12891. Oncotarget. 2017. PMID: 27793012 Free PMC article. Review.
Cited by
-
GPER activation attenuates cardiac dysfunction by upregulating the SIRT1/3-AMPK-UCP2 pathway in postmenopausal diabetic rats.PLoS One. 2023 Dec 22;18(12):e0293630. doi: 10.1371/journal.pone.0293630. eCollection 2023. PLoS One. 2023. PMID: 38134189 Free PMC article.
-
The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos.Int J Mol Sci. 2019 Dec 2;20(23):6066. doi: 10.3390/ijms20236066. Int J Mol Sci. 2019. PMID: 31810173 Free PMC article.
-
Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength.Bone. 2019 Jun;123:137-144. doi: 10.1016/j.bone.2019.03.033. Epub 2019 Mar 28. Bone. 2019. PMID: 30930293 Free PMC article. Review.
-
The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.Semin Cell Dev Biol. 2016 Jun;54:53-67. doi: 10.1016/j.semcdb.2015.11.005. Epub 2015 Dec 1. Semin Cell Dev Biol. 2016. PMID: 26593326 Free PMC article. Review.
-
Diminished satellite cells and elevated adipogenic gene expression in muscle as caused by ovariectomy are averted by low-magnitude mechanical signals.J Appl Physiol (1985). 2015 Jul 1;119(1):27-36. doi: 10.1152/japplphysiol.01020.2014. Epub 2015 Apr 30. J Appl Physiol (1985). 2015. PMID: 25930028 Free PMC article.
References
-
- Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–11. - PubMed
-
- Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003;113:159–70. - PubMed
-
- D’Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005;280:35983–91. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous